Literature DB >> 15000345

Nicotine and angiogenesis: a new paradigm for tobacco-related diseases.

John P Cooke1, Haim Bitterman.   

Abstract

The pathophysiology of tobacco-related diseases is complex and multifactorial. Among the approximately 4,000 compounds in tobacco smoke are carcinogens such as nitrosamines, irritants such as a variety of phenolic compounds, volatiles such as carbon monoxide, and of course nicotine. Nicotine itself has quite complex actions, mediated in part by nicotinic cholinergic receptors that may have extraneuronal, as well as neuronal distribution. This review discusses the mechanisms by which nicotine contributes to tobacco-related disease, with a focus on the surprising new finding that nicotine is a potent angiogenic agent. Nicotine hijacks an endogenous nicotinic cholinergic pathway present in endothelial cells that is involved in physiological, as well as pathological angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15000345     DOI: 10.1080/07853890310017576

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  26 in total

1.  Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo.

Authors:  Jan Bucerius; Christoph Manka; Jörn Schmaljohann; Venkatesh Mani; Daniela Gündisch; James H F Rudd; Rolf Bippus; Felix M Mottaghy; Ullrich Wüllner; Zahi A Fayad; Hans-Jürgen Biersack
Journal:  JACC Cardiovasc Imaging       Date:  2012-05

2.  [Effects of nicotine with special consideration given to tumorigenesis in the head and neck region].

Authors:  M P Semmler; O Driemel; R Staudenmaier; K Froelich; N H Kleinsasser
Journal:  Mund Kiefer Gesichtschir       Date:  2006-11

3.  Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: a diffusion tensor imaging study.

Authors:  Robert H Paul; Stuart M Grieve; Raymond Niaura; Sean P David; David H Laidlaw; Ronald Cohen; Lawrence Sweet; George Taylor; Richard C Clark; Sakire Pogun; Evian Gordon
Journal:  Nicotine Tob Res       Date:  2008-01       Impact factor: 4.244

4.  Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States.

Authors:  Benjamin J Apelberg; Georgiana Onicescu; Erika Avila-Tang; Jonathan M Samet
Journal:  Am J Public Health       Date:  2009-12-17       Impact factor: 9.308

5.  [Does nicotine add to the carcinogenic strain of tobacco smoke?].

Authors:  N H Kleinsasser; A W Sassen; M P Semmler; R Staudenmaier; U A Harréus; E Richter
Journal:  HNO       Date:  2006-05       Impact factor: 1.284

6.  β-cryptoxanthin restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and emphysema in A/J mice.

Authors:  Anita R Iskandar; Chun Liu; Donald E Smith; Kang-Quan Hu; Sang-Woon Choi; Lynne M Ausman; Xiang-Dong Wang
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-28

7.  Topical mecamylamine for diabetic macular edema.

Authors:  Peter A Campochiaro; Syed Mahmood Shah; Gulnar Hafiz; Jeffery S Heier; Eugene S Lit; Ingrid Zimmer-Galler; Roomasa Channa; Quan Dong Nguyen; Beena Syed; Diana V Do; Lili Lu; James Monk; John P Cooke; M Ken Kengatharan; Henry H Hsu
Journal:  Am J Ophthalmol       Date:  2010-02-26       Impact factor: 5.258

Review 8.  Endothelial nicotinic acetylcholine receptors and angiogenesis.

Authors:  John P Cooke; Yohannes T Ghebremariam
Journal:  Trends Cardiovasc Med       Date:  2008-10       Impact factor: 6.677

9.  Chronic exposure to nicotine impairs cholinergic angiogenesis.

Authors:  Hakuoh Konishi; Jenny Wu; John P Cooke
Journal:  Vasc Med       Date:  2009-09-24       Impact factor: 3.239

10.  Chronic smoking and the BOLD response to a visual activation task and a breath hold task in patients with schizophrenia and healthy controls.

Authors:  Lee Friedman; Jessica A Turner; Hal Stern; Daniel H Mathalon; Liv C Trondsen; Steven G Potkin
Journal:  Neuroimage       Date:  2008-01-05       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.